References and Notes
- 1
Tumlinson JH.
Hardee DD.
Gueldner RC.
Thompson AC.
Hedin PA.
Minyard JP.
Science
1969,
166:
1010
-
2a
Jones JB.
Finch MAW.
Jakovac IJ.
Can.
J. Chem.
1982,
60:
2007
-
2b
Meyers AI.
Fleming SA.
J.
Am. Chem. Soc.
1986,
108:
306
-
2c
Demuth M.
Palomer A.
Sluma H.-D.
Dey AK.
Krüger C.
Tsay Y.-H.
Angew. Chem.
1986,
98:
128
-
2d
Rosini G.
Marotta E.
Raimondi A.
Righi P.
Tetrahedron: Asymmetry
1991,
2:
123
-
2e
Hayashi Y.
Narasaka K.
Bull. Chem. Soc. Jpn.
1991,
64:
1471
-
2f
Okano K.
Ebata T.
Koseki K.
Kawakami H.
Matsumoto K.
Matsushita H.
Chem. Pharm. Bull.
1993,
41:
861
-
2g
Toya T.
Nagase H.
Honda T.
Tetrahedron:
Asymmetry
1993,
4:
1537
-
2h
Langer K.
Mattay J.
J. Org. Chem.
1995,
60:
7256
-
2i
de March P.
Figueredo M.
Font J.
Raya J.
Org. Lett.
2000,
2:
163
-
2j
de March P.
Figueredo M.
Font J.
Raya J.
Alvarez-Larena A.
Piniella JF.
J. Org. Chem.
2003,
68:
2437
-
2k
Hamon DPG.
Tuck KL.
Tetrahedron
Lett.
1999,
40:
7569
-
2l
Hamon DPG.
Tuck KL.
J.
Org. Chem.
2000,
65:
7839
-
2m
Bernard AM.
Frongia A.
Ollivier J.
Piras PP.
Secci F.
Spiga M.
Tetrahedron
2007,
63:
4968
- 3
Bernard AM.
Frongia A.
Secci F.
Delogu G.
Ollivier J.
Piras PP.
Salaün J.
Tetrahedron
2003,
59:
9433
- 4
Cho SY.
Cha JK.
Org. Lett.
2000,
2:
1337
- 5
James KD.
Ekwuribe NN.
Tetrahedron
2002,
58:
5905
- 6
Seebach D.
Naef R.
Calderari G.
Tetrahedron
1984,
40:
1313
- 8
Ohba M.
Izuta R.
Shimizu E.
Chem. Pharm.
Bull.
2006,
54:
63
-
9a
Kulinkovich OG.
Sviridov SV.
Vasilevski DA.
Savchenko AI.
Prityskaya TS.
J.
Org. Chem. USSR (Engl. Transl.)
1989,
25:
2027
-
9b
Kulinkovich OG.
Sviridov SV.
Vasilevski DA.
Savchenko AI.
Prityskaya TS.
J. Org. Chem.
USSR (Engl. Transl.)
1991,
27:
250
-
9c
Kulinkovich OG.
Sviridov SV.
Vasilevski DA.
Synthesis
1991,
234
- 10
Garnier J.-M.
Jida M.
Ollivier J.
Synlett
2006,
2739
- 12
Yu S.-H.
Park J.-J.
Chung S.-K.
Tetrahedron:
Asymmetry
2006,
17:
3030
7
Reduction Procedure:
To a solution of [(4S)-4-methyl-5-oxo-2-(tribromomethyl)-1,3-dioxolan-4-yl]acetic
acid (4; 2.64 g, 6.45 mmol) in anhyd THF
(15 mL) was added dropwise at -10 ˚C under argon
a solution of borane methyl sulfide complex (1.75 mL, 3.48 mmol,
2 M in THF). After stirring for an additional hour at -10 ˚C,
the reaction mixture was allowed to warm overnight to r.t. The mixture
was quenched with MeOH (1 mL) and concentrated under reduced pressure
and the resulting oil was diluted in Et2O (50 mL). The
ethereal phase was washed with brine (5 mL) and then dried over
Na2SO4. After evaporation of the solvent,
the residue was purified by flash chromatography to afford pure
(3S)-dihydro-3-hydroxy-3-methyl-2(3H)-furanone (5;
0.65 g, 83%); [α]D
²0 -32.2
(c 0.1, CHCl3).
11 Crystallographic data for (-)-9: C13H28O3Si,
M = 260.44, monoclinic, space group C2,
a = 12.359(5) Å, b = 7.468(5) Å,
c = 17.642(5) Å, β = 101.69˚, Z = 2, V = 1594.54 ų.
Full crystallographic data have been deposited with the Cambridge
Crystallographic Data Centre CCDC as supplementary publication number
CCDC 697709. Copies of the data can be obtained free of charge on
application to CCDC, 12 Union Road, Cambridge, CB2 IEZ, UK, fax:
+44
(1223)336033, e-mail: deposit@ccdc.cam.ac.uk; www.ccdc.cam.ac.uk/data_request/cif.
13 Selected data:
1-[(1
S
)-1-(
tert
-Butyldimethylsilyloxy)-3-hydroxy-1-methylpropyl]cyclopropanol
(9): colorless needles; mp
65 ˚C; [α]D
²0 -12
(c 0.1, CHCl3). IR (KBr):
3289, 2957, 1464, 1254 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 3.94-4.03
(m, 1 H), 3.64-3.78 (m, 1 H), 2.02-2.07 (m, 1
H), 1.70-1.87 (m, 1 H), 1.31 (s, 3 H), 0.82-0.97
(m, 2 H), 0.84 (s, 9 H), 0.59-0.64 (m, 2 H), 0.11 (s, 3
H), 0.07 (s, 3 H). ¹³C NMR (62.9 MHz,
CDCl3): δ = 75.3, 60.1, 58.3, 43.0,
41.9, 25.2, 11.4, 8.2, 2.6, 2.3. HRMS (ES, +): m/z calcd
for C13H28O3SiNa: 283.17054; found:
283.17058.
1-[(1
S
)-3-(Benzyloxy)-1-(
tert
-butyldimethylsilyloxy)-1-methylpropyl]cyclopropanol
(12): colorless oil; [α]D
²0 -34 (c 0.05, CHCl3). IR (neat):
3501, 2929, 1454, 1256 cm-¹.
¹H
NMR (300 MHz, CDCl3): δ = 7.29-7.37
(m, 5 H), 4.54 (Abq, J = 3.3
Hz, 2 H), 3.96-4.03 (m, 1 H), 3.71-3.78 (m,
1
H), 3.69 (s, 1 H), 1.99-2.15 (m, 1 H), 1.89-1.97
(m, 1 H), 1.27 (s, 3 H), 0.76-0.93 (m, 2 H), 0.87 (s, 9
H), 0.59-0.63 (m, 2 H), 0.10 (s, 3 H), 0.06 (s, 3 H). ¹³C
NMR (62.9 MHz, CDCl3): δ = 129.2, 128.4,
128.2, 126.9, 78.2, 58.6, 40.0, 37.3, 29.2, 26.2, 25.6, 9.4, 7.5,
2.8, 2.3. HRMS (ES, +): m/z calcd for C19H34O3SiNa:
373.21749; found: 373.21712.
(2
R
)-2-(2-Benzyloxyethyl)-2-methylcyclobutanone
(2): colorless oil; [α]D
²4 +42
(c 0.1, CHCl3). IR (neat):
1765
cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 7.30 (m,
5 H), 4.43 (Abq, J = 11.7 Hz,
2 H), 3.56 (t, J = 6.3 Hz, 2
H), 2.98 (t,
J = 6.3
Hz, 2 H), 1.93-2.01 (m, 2 H), 1.86 (s, 3 H), 1.64-1.79 (m,
2 H). ¹³C NMR (62.9 MHz, CDCl3): δ = 214.8,
138.1, 128.2, 127.4, 127.3, 72.8, 66.7, 62.2, 42.3, 35.3, 23.9,
21.3. MS (EI): m/z (%) = 218 (1) [M+],
127 (12), 97 (11), 91 (100), 41 (38).